Pharvaris N.V. (PHVS)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Johannes Gerardus Christiaan Petrus SchikanJohannes Gerardus Christiaan Petrus SchikanPharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 19 | 160,317 | $5.62M |
| Option exercise | 21 | 140,644 | |
| Tax withholding / forfeiture | 6 | 678 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Apr 3, 2026, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peng Lu - Officer | Option exercise | Common Stock | 7,001 | $2.59 | $18K | |
| Peng Lu - Officer | Open-market sale | Common Stock | 7,001 | $30.05 | $210K | |
| Peng Lu - Officer | Option exercise | Common Stock | 100 | $2.59 | $259 | |
| Peng Lu - Officer | Open-market sale | Common Stock | 100 | $30.03 | $3K | |
| Peng Lu - Officer | Option exercise | Stock Option (Right to Buy) | 7,001 | $0.00 | - | |
| Peng Lu - Officer | Option exercise | Stock Option (Right to Buy) | 100 | $0.00 | - | |
| Peng Lu - Officer | Tax withholding / forfeiture | Common Stock | 226 | $28.78 | $7K | |
| Berndt Modig - Officer | Open-market sale | Common Stock | 2,292 | $28.60 | $66K | |
 Anna Nijdam - Officer | Tax withholding / forfeiture | Common Stock | 548 | $26.63 | $15K | |
| Berndt Modig - Officer | Open-market sale | Common Stock | 23,133 | $27.74 | $642K | |
| Berndt Modig - Officer | Open-market sale | Common Stock | 200 | $28.42 | $6K | |
| Anna Nijdam - Officer | Tax withholding / forfeiture | Common Stock | 1,167 | $28.56 | $33K | |
| Anna Nijdam - Officer | Tax withholding / forfeiture | Common Stock | 1,164 | $28.25 | $33K |
This is as far as the anonymous view goes. Create a free account for all 37 PHVS filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Berndt B.A,E. Modig | Director, Officer | 2,292 | $78K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Pharvaris N.V. (PHVS) had 14 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for PHVS runs to 37 Form 4 filings, the earliest from 2026-04-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PHVS were filed in the last 90 days.
19 insider sales of PHVS were filed in the last 90 days, totaling $5.62M.
This page tracks PHVS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PHVS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
